pk 11195 has been researched along with Dyskinesia, Medication-Induced in 2 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raghavendra, V | 1 |
| Naidu, PS | 1 |
| Kulkarni, SK | 1 |
| Weizman, R | 1 |
| Tanne, Z | 1 |
| Karp, L | 1 |
| Tyano, S | 1 |
| Gavish, M | 1 |
2 other studies available for pk 11195 and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Antineoplastic Agents; Dose-Res | 2001 |
Peripheral-type benzodiazepine-binding sites in platelets of schizophrenics with and without tardive dyskinesia.
Topics: Adult; Binding Sites; Blood Platelets; Dyskinesia, Drug-Induced; Female; Humans; Isoquinolines; Male | 1986 |